Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
somatropin pegol
- Development stage
- Phase 2
- Lead developer
- Novo Nordisk
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Subcutaneous
01
Overview
Somatropin pegol is a long-acting, investigational form of human growth hormone (hGH) designed for the treatment of growth hormone deficiency. It is a pegylated (polyethylene glycol-conjugated) recombinant human growth hormone, which extends its half-life and allows for less frequent dosing compared to standard somatropin. The drug acts by binding to the growth hormone receptor, stimulating skeletal and muscle growth as well as protein production, mimicking the effects of endogenous hGH. Somatropin pegol has been studied in clinical trials for use in adults and children with growth hormone deficiency[2][4].
- Brand names
- Somatropin pegol
- Other names
- somatropin pegol
02
Targets
GHR (Growth hormone receptor)
Beyond the preview
Go deeper on somatropin pegol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on somatropin pegol.